ZMAC Trademark

Trademark Overview


On Thursday, August 15, 2019, a trademark application was filed for ZMAC with the United States Patent and Trademark Office. The USPTO has given the ZMAC trademark a serial number of 88580595. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by Aptimmune Biologics, Inc.. The ZMAC trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

cells for manufacturing antigens used in veterinary vaccines

cells for scientific and research use
zmac

General Information


Serial Number88580595
Word MarkZMAC
Filing DateThursday, August 15, 2019
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6240792
Registration DateTuesday, January 5, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements


Goods and Servicescells for manufacturing antigens used in veterinary vaccines
Goods and Servicescells for scientific and research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, August 31, 2019
Primary Code001
First Use Anywhere DateMonday, August 3, 2020
First Use In Commerce DateMonday, August 3, 2020

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 31, 2019
Primary Code005
First Use Anywhere DateMonday, August 3, 2020
First Use In Commerce DateMonday, August 3, 2020

Trademark Owner History


Party NameAptimmune Biologics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63132

Party NameAptimmune Biologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63132

Party NameAptimmune Biologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63132

Trademark Events


Event DateEvent Description
Monday, August 19, 2019NEW APPLICATION ENTERED
Saturday, August 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Friday, November 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 10, 2020TEAS STATEMENT OF USE RECEIVED
Friday, August 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 10, 2020USE AMENDMENT FILED
Friday, August 21, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, September 14, 2020SU - NON-FINAL ACTION - WRITTEN
Monday, September 14, 2020NON-FINAL ACTION E-MAILED
Monday, September 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 1, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 2, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED